Recent data published in the Annals of Internal Medicine reveals a significant structural dynamic within the regulated medical cannabis sector. According to University of Michigan researchers, state-approved medical cannabis caregivers outnumber authorized certifying clinicians by a ratio of three to one. The study tracked public state records from 2024, identifying nearly 110,000 active caregivers compared to roughly 35,000 authorized physicians and medical professionals.
This disparity highlights the reliance patients place on secondary support systems to access therapeutic cannabis products. As state programs continue to evolve, the operational bottleneck caused by limited physician participation places immense pressure on caregivers to navigate product selection, dosing, and purchasing on behalf of patients. Dispensary operators and brand managers must recognize that caregivers frequently act as the primary decision-makers at the retail counter.
Understanding this dynamic shifts how retail staff should approach customer service and product education. Rather than focusing solely on the end patient, staff training programs need to address the specific needs, compliance hurdles, and product preferences of caregivers. Brands targeting the medical segment should consider how their packaging and labeling communicate efficacy and dosing clearly, as caregivers often manage complex medication schedules for multiple individuals.
This caregiver-to-clinician ratio underscores an ongoing access gap in medical marijuana markets—one that retail environments and product manufacturers must accommodate to capture market share effectively.